NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Christopher Nutting
Royal Marsden Hospital - London / United Kingdom
Others
AD Scientific Index ID: 4922986
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Christopher Nutting's MOST POPULAR ARTICLES
1-)
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialCM Nutting, JP Morden, KJ Harrington, TG Urbano, SA Bhide, C Clark, ...The lancet oncology 12 (2), 127-136, 201116392011
2-)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialMS Brose, CM Nutting, B Jarzab, R Elisei, S Siena, L Bastholt, ...The Lancet 384 (9940), 319-328, 20141417*2014
3-)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialH Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...The Lancet 393 (10166), 51-60, 20197032019
4-)
Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelinesV Grégoire, K Ang, W Budach, C Grau, M Hamoir, JA Langendijk, A Lee, ...Radiotherapy and Oncology 110 (1), 172-181, 20148562014
5-)
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerU Mallick, C Harmer, B Yap, J Wadsley, S Clarke, L Moss, A Nicol, ...New England Journal of Medicine 366 (18), 1674-1685, 20127622012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept